For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240730:nRSd4428Ya&default-theme=true
RNS Number : 4428Y Judges Scientific PLC 30 July 2024
Judges Scientific plc
Director/PDMR Shareholding
In accordance with notification obligations under article 19.3 of the Market
Abuse Regulation, the Company announces that on 30 July 2024 David Cicurel,
CEO, transferred by way of a gift 40,000 ordinary shares of 5 pence each in
the Company ("Ordinary Shares") in aggregate to his adult children.
Following this gift David Cicurel is beneficially interested in 604,337
Ordinary Shares and beneficially and non beneficially interested in
671,337 Ordinary Shares, his non beneficial interest comprising 67,000
Ordinary Shares he has gifted to Shoftim Charitable Trust.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name David Cicurel
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Judges Scientific plc
b) LEI 2138004EXWWPTW1JOL31
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in Judges Scientific plc
Identification code
GB0032398678
b) Nature of the transaction Gift of 40,000 Ordinary Shares to adult children
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil consideration 40,000
d) Aggregated information
N/A (single transaction)
- Aggregated volume
- Price
e) Date of the transaction 30/07/2024
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
30/07/2024
f)
Place of the transaction
Outside a trading venue
- For further information please contact:
Judges Scientific plc Shore Capital (Nominated Adviser & Joint Broker)
David Cicurel, CEO Stephane Auton
Brad Ormsby, CFO Harry Davies-Ball
Tel: +44 (0) 20 3829 6970 Tel: +44 (0) 20 7408 4090
Liberum (Joint Broker) Investec Bank plc (Joint Broker)
Edward Mansfield Virginia Bull
Nikhil Varghese Carlton Nelson
Tel : +44 (0) 20 3100 2222 Tel: +44 (0) 207 597 4000
Alma PR (Financial Public Relations)
Sam Modlin
Rebecca Sanders-Hewitt
Joe Pederzolli
Tel: +44 (0) 20 3405 0205
judges@almastrategic.co.uk (mailto:judges@almastrategic.co.uk)
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and
developing companies in the scientific instrument sector. The Group now
consists of 24 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to
a diverse range of markets including: higher education institutions,
scientific research facilities, manufacturers and regulatory authorities. The
UK is a recognised centre of excellence for scientific instruments. The Group
has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long
term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that
generate sustainable profits and cash. Shareholder returns are created through
the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com (//www.judges.uk.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBXGDRXSXDGSG